Roche

Big pharma’s biggest spenders revealed
EP Vantage
Tue, 05/17/22 - 10:29 am
R&D
licensing
M&A
COVID-19
Big Pharma
Bristol Myers Squibb
JNJ
AbbVie
Sanofi
Merck
Novartis
Pfizer
AstraZeneca
Roche
GSK
Eli Lilly
EHA 2022 preview – some good news at last
EP Vantage
Mon, 05/16/22 - 10:14 am
EHA
Caribou Biosciences
CB-010
Gracell
Autolus
Roche
Curocell
ADC Therapeutics
Mustang Bio
Checkmate details bleak future if $250M Regeneron merger does not close
Fierce Biotech
Sun, 05/15/22 - 11:17 pm
Checkmate Pharmaceuticals
Roche
M&A
Novartis' Sandoz strikes at Roche with first US generic of blockbuster Esbriet
Fierce Pharma
Fri, 05/13/22 - 10:46 am
Novartis
Sandoz
generics
Roche
Esbriet
idiopathic pulmonary fibrosis
Opportunities arise for once-spurned partners
EP Vantage
Fri, 05/13/22 - 10:34 am
Pfizer
Biohaven
licensing
M&A
Aurinia
Bristol Myers Squibb
AbbVie
Alector
Arcus Biosciences
Biogen
Blueprint Medicines
CureVac
Gilead Sciences
GSK
Incyte
MorphoSys
Roche
Nestle
SAGE Therapeutics
Sarepta Therapeutics
Seres Therapeutics
Syndax
Roche believes cancer drug setback not a fatal blow to growth prospects
Reuters
Thu, 05/12/22 - 10:57 pm
Roche
drug development
tiragolumab
Eylea keeps its lead in the retinal space as physicians remain hesitant on Roche's Susvimo — report
Endpoints
Thu, 05/12/22 - 10:44 pm
Roche
Susvimo
wet age-related macular degeneration
physicians
Strike 2: Roche flunks another phase 3 lung cancer test to leave TIGIT space reeling
Fierce Biotech
Wed, 05/11/22 - 10:38 am
Roche
tiragolumab
anti-TIGIT
non-small cell lung cancer
clinical trials
Record-breaking 2021 revenue shows there's more to Swiss biotech sector than Roche, Novartis
Fierce Biotech
Wed, 05/4/22 - 10:30 am
biotech
Switzerland
Novartis
Roche
Sophia Genetics
CRISPR Therapeutics
Roche delays DMD drug deadline, decides to rejig MS trials because of Ukraine war
Fierce Biotech
Tue, 04/26/22 - 10:33 am
Roche
Ocrevus
clinical trials
Duchenne Muscular Dystrophy
Roche’s oral SERD giredestrant fails breast cancer trial
Pharmaforum
Mon, 04/25/22 - 10:48 am
Roche
breast cancer
SERD
Giredestrant
clinical trials
Roche posted a big Q1 sales gain. So why is the company expecting a slowdown later this year?
Fierce Pharma
Mon, 04/25/22 - 10:47 am
Roche
earnings
COVID-19
Ocrevus
diagnostics
Outside of big pharma, life remains tough for listed developers
EP Vantage
Wed, 04/20/22 - 10:38 am
pharma stocks
AbbVie
AstraZeneca
BeiGene
BioNTech
Moderna Therapeutics
Pfizer
Roche
Roche Wakes Up to New Competition as FDA Approves Amneal’s Avastin Biosimilar
BioSpace
Thu, 04/14/22 - 10:57 am
Amneal
FDA
bevacizumab-maly
Genentech
Roche
Avastin
biosimilars
Turning Point looks to challenge Pfizer, Roche with new early data for lead lung cancer drug
Endpoints
Wed, 04/13/22 - 05:37 pm
Turning Point Therapeutics
Pfizer
Roche
repotrectinib
clinical trials
non-small cell lung cancer
Federal appeals court overturns $137M patent verdict against Roche — but the case isn't closed just yet
Endpoints
Mon, 04/11/22 - 07:21 pm
Roche
legal
patents
Roche Diagnostics
Medtech
Cobas
Meso Scale
20 years in, Genentech persists and perseveres in Alzheimer's with gantenerumab
Fierce Biotech
Wed, 04/6/22 - 07:44 pm
Roche
Genentech
Alzheimer's disease
gantenerumab
Roche's closely watched immunotherapy fails key study in tough-to-treat lung cancer
BioPharma Dive
Wed, 03/30/22 - 10:54 am
Roche
tiragolumab
clinical trials
Tigit
advanced small cell lung cancer
Merck, Roche and J&J among pharma players weighing Russian operations amid humanitarian tightrope walk
Fierce Pharma
Tue, 03/29/22 - 11:43 pm
Merck
JNJ
Roche
Russia
Ukraine
Roche's Chugai pays Halozyme $25M to access subcutaneous delivery tech
Fierce Biotech
Tue, 03/29/22 - 10:36 am
Roche
Chugai
drug delivery
subcutaneous drug delivery
Haolzyme Therapeutics
Enhanze

Pages